The human microbiome: A promising target for lung cancer treatment.

Sun, Ying; Wen, Miaomiao; Liu, Yue; Wang, Yu; Jing, Pengyu; Gu, Zhongping; Jiang, Tao; Wang, Wenchen

Sun, Ying; Wen, Miaomiao; Liu, Yue; Wang, Yu; Jing, Pengyu; Gu, Zhongping; Jiang, Tao; Wang, Wenchen.

Affiliation

Sun Y; Department of Thoracic Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an, China.
Wen M; Department of Thoracic Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an, China.
Liu Y; Department of Thoracic Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an, China.
Wang Y; Department of Thoracic Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an, China.
Jing P; Department of Thoracic Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an, China.
Gu Z; Department of Thoracic Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an, China.
Jiang T; Department of Thoracic Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an, China.
Wang W; Department of Thoracic Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an, China.

Front Immunol ; 14: 1091165, 2023.

Article de En | MEDLINE | ID: mdl-36817461

Sujet(s)
Mots clés

clinical application; immunology; lung cancer; malignant mechanism; microbiome; pulmonary infection

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Microbiote / Tumeurs du poumon Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Front Immunol Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google